Some flavonoids have been shown to inhibit P-gp via different mechanisms, including a decrease in P-gp expression [109], interference with ATP hydrolysis [110], and blockade of the binding site [111], thereby inhibiting the efflux of chemotherapeutic drugs from cancer cells and reversing their chemoresistance. The gene discussed is PGP; the disease is cancer.